Boson has participated in the AACC exhibition in the USA from 26-28 July 2022, which ended successfully yesterday.

At the exhibition, Boson Biotech exhibited rapid test reagents including COVID-19 test, infectious disease test and FOB test, etc., which were warmly welcomed by the attending customers. One of the most popular products is the FDA EUA Authorized Rapid SARS-CoV-2 Antigen Test Card for home use, the customers showed a high level of interest in the product.

The exhibition also heralds the further expansion of Boson Biotech into the North American market. After obtaining FDA EUA Authorization and Health Canada Emergency Authorization for COVID-19 products, Boson Biotech will also expand the registration of other products in the North American market, as well as the registration of COVID-19 products in other markets.